Recently added

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing

Rowlands, Charlie; Allen, Sophie; Domchek, Susan; Evans, Gareth; Hanson, Helen L.; Balmaña, Judith (Elsevier, 2024-10)

Metastatic hormone-naïve prostate cancer: a distinct biological entity

Corres-Mendizabal, Jon; Martín-Martín, Natalia; Carracedo, Arkaitz; Zacchi, Francesca; Mateo, Joaquin (Elsevier, 2024-09)

Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease

Garcia Rodriguez, Ariadna; Salvà, Francesc; Saoudi Gonzalez, Nadia; R Castells, Marta; Baraibar, Iosune; Ros, Javier; Tabernero, Josep; Elez, Elena (Elsevier, 2024-09)

PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

Redondo Sanchez, Andres; George, A.; Chui, Stephen; Kristeleit, Rebecca; leary, alexandra; OAKNIN, ANA (Springer Nature, 2024-07)

Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study

Cirauqui, Beatriz; AKSOY, SERCAN; Couture, Felix; Hong, Ruey-Long; Cho, Byoung Chul; Brana, Irene (BMC, 2024-07-25)

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing

Metastatic hormone-naïve prostate cancer: a distinct biological entity

Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease

PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study

Scientia. Department of Health Digital Information Depot

VHIO - Articles científics: Recent submissions

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing ﻿

Metastatic hormone-naïve prostate cancer: a distinct biological entity ﻿

Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease ﻿

PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers ﻿

Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study ﻿

Population-based germline breast cancer gene association studies and meta-analysis to inform wider mainstream testing

Metastatic hormone-naïve prostate cancer: a distinct biological entity

Determinants of Metastatic Colorectal Cancer With Permanent Liver- Limited Disease

PARP inhibition with rucaparib alone followed by combination with atezolizumab: Phase Ib COUPLET clinical study in advanced gynaecological and triple-negative breast cancers

Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label study